PBE Holdings List

As of Dec 19, 2024

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	5.27%	142,221
2	UTHR	United Therapeutics Corporation	5.12%	34,909
3	NTRA	Natera, Inc.	5.04%	78,287
4	REGN	Regeneron Pharmaceuticals, Inc.	4.95%	17,171
5	ILMN	Illumina, Inc.	4.88%	89,484
6	BIIB	Biogen Inc.	4.86%	81,088
7	INCY	Incyte Corporation	4.78%	175,048
8	AMGN	Amgen Inc.	4.65%	43,774
9	NBIX	Neurocrine Biosciences, Inc.	3.03%	55,226
10	SRPT	Sarepta Therapeutics, Inc.	2.98%	61,228
11	ETR: QIA	Qiagen N.V.	2.93%	162,307
12	EXAS	Exact Sciences Corporation	2.91%	127,309
13	BCRX	BioCryst Pharmaceuticals, Inc.	2.90%	965,579
14	CPRX	Catalyst Pharmaceuticals, Inc.	2.89%	331,277
15	ACAD	ACADIA Pharmaceuticals Inc.	2.89%	424,411
16	BMRN	BioMarin Pharmaceutical Inc.	2.85%	107,847
17	HALO	Halozyme Therapeutics, Inc.	2.83%	146,888
18	COLL	Collegium Pharmaceutical, Inc.	2.82%	227,988
19	TECH	Bio-Techne Corporation	2.74%	94,364
20	VCYT	Veracyte, Inc.	2.72%	170,797
21	BPMC	Blueprint Medicines Corporation	2.71%	74,781
22	MNKD	MannKind Corporation	2.68%	1,044,607
23	EXEL	Exelixis, Inc.	2.64%	192,956
24	XNCR	Xencor, Inc.	2.63%	269,369
25	AXSM	Axsome Therapeutics, Inc.	2.63%	71,998
26	RPRX	Royalty Pharma plc	2.62%	265,197
27	TGTX	TG Therapeutics, Inc.	2.55%	202,824
28	PTGX	Protagonist Therapeutics, Inc.	2.48%	154,178
29	CDNA	CareDx, Inc	2.43%	291,156
30	MYGN	Myriad Genetics, Inc.	2.39%	446,835
31	AGPXX	Invesco Government & Agency Portfolio	0.21%	519,459
32	-CASH-	Cash/Receivables/Payables	0.00%	5,728

As of Dec 19, 2024